Brief: Bavarian Nordic Gets USD 22.5 Mln Deal For Mpox, Smallpox Vaccine
Feb 18 (Reuters) - Bavarian Nordic A/S BAVA.CO: BAVARIAN NORDIC RECEIVES USD 22.5 MILLION CONTRACT FOR ITS MPOX AND SMALLPOX VACCINE FROM THE GOVERNMENT OF CANADA Source text: ID:nGNE1HC4G1 Further company coverage: BAVA.CO (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Bavarian Nordic A/S
See all newsBrief: Bavarian Nordic Completes First Tranche Of Share Buy-Back Program
Bavarian Nordic gets four-year contract for mpox and smallpox vaccine from UK government
Brief: Bavarian Nordic Awarded Multi-Year Vaccine Contract By UK Government
Bavarian Nordic donates 75,000 mpox vaccine doses to global emergency stockpile
Brief: Bavarian Nordic Donates To Global Mpox Emergency Stockpile